Natural products as modulators of CES1 activity

Y Qian, JS Markowitz - Drug Metabolism and Disposition, 2020 - ASPET
Carboxylesterase (CES) 1 is the predominant esterase expressed in the human liver and is
capable of catalyzing the hydrolysis of a wide range of therapeutic agents, toxins, and …

Carboxylesterase 1 and precision pharmacotherapy: pharmacogenetics and nongenetic regulators

L Her, HJ Zhu - Drug Metabolism and Disposition, 2020 - ASPET
Carboxylesterase (CES) 1 is the most abundant drug-metabolizing enzyme in human livers,
comprising approximately 1% of the entire liver proteome. CES1 is responsible for 80 …

Regulation of carboxylesterases and its impact on pharmacokinetics and pharmacodynamics: an up-to-date review

Y Liu, J Li, HJ Zhu - Expert Opinion on Drug Metabolism & …, 2024 - Taylor & Francis
ABSTRACT Introduction Carboxylesterase 1 (CES1) and carboxylesterase 2 (CES2) are
among the most abundant hydrolases in humans, catalyzing the metabolism of numerous …

Carboxylesterase inhibitors from clinically available medicines and their impact on drug metabolism

YQ Song, Q Jin, DD Wang, J Hou, LW Zou… - Chemico-Biological …, 2021 - Elsevier
Mammalian carboxylesterases (CES), the key members of the serine hydrolase superfamily,
hydrolyze a wide range of endogenous substances and xenobiotics bearing ester or amide …

The impact of carboxylesterases in drug metabolism and pharmacokinetics

L Di - Current drug metabolism, 2019 - ingentaconnect.com
Background: Carboxylesterases (CES) play a critical role in catalyzing hydrolysis of esters,
amides, carbamates and thioesters, as well as bioconverting prodrugs and soft drugs. The …

In vitro drug metabolism by human carboxylesterase 1: focus on angiotensin-converting enzyme inhibitors

R Thomsen, HB Rasmussen, K Linnet… - Drug Metabolism and …, 2014 - ASPET
Carboxylesterase 1 (CES1) is the major hydrolase in human liver. The enzyme is involved in
the metabolism of several important therapeutic agents, drugs of abuse, and endogenous …

Individualization of treatments with drugs metabolized by CES1: combining genetics and metabolomics

HB Rasmussen, D Bjerre, K Linnet, G Jürgens… - …, 2015 - Taylor & Francis
CES1 is involved in the hydrolysis of ester group-containing xenobiotic and endobiotic
compounds including several essential and commonly used drugs. The individual variation …

Potential pharmacokinetic herb-drug interactions: have we overlooked the importance of human carboxylesterases 1 and 2?

J Xu, JC Qiu, X Ji, HL Guo, X Wang… - Current Drug …, 2019 - ingentaconnect.com
Background: Herbal products have grown steadily across the globe and have increasingly
been incorporated into western medicine for healthcare aims, thereby causing potential …

[HTML][HTML] Human carboxylesterases: a comprehensive review

D Wang, L Zou, Q Jin, J Hou, G Ge, L Yang - Acta Pharmaceutica Sinica B, 2018 - Elsevier
Mammalian carboxylesterases (CEs) are key enzymes from the serine hydrolase
superfamily. In the human body, two predominant carboxylesterases (CES1 and CES2) …

Carboxylesterase inhibitors: an update

LW Zou, Q Jin, DD Wang, QK Qian… - Current medicinal …, 2018 - ingentaconnect.com
Mammalian carboxylesterases are key serine hydrolases that catalyze the hydrolysis of a
wide variety of ester compounds in the corresponding carboxylic acids and alcohols. In …